Published in Eur J Cancer on April 01, 1990
Chemotherapy for malignant brain tumors of childhood. J Child Neurol (2008) 1.14
Adult medulloblastoma: prognostic factors and response to therapy at diagnosis and at relapse. J Neurol (2005) 1.11
High-risk medulloblastoma: a pediatric oncology group randomized trial of chemotherapy before or after radiation therapy (POG 9031). J Clin Oncol (2013) 1.10
Childhood brain tumors: epidemiology, current management and future directions. Nat Rev Neurol (2011) 1.09
Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis. Lancet Oncol (2016) 0.95
Prognostic significance of the c-erbB-2 oncogene product in childhood medulloblastoma. Br J Cancer (1995) 0.95
Outcome of children with posterior fossa medulloblastoma: a single institution experience over the decade 1994-2003. Childs Nerv Syst (2006) 0.91
Advances in treatment of pediatric brain tumors. NeuroRx (2006) 0.87
Does diagnostic delay result in decreased survival in paediatric brain tumours? Eur J Pediatr (2008) 0.86
An intensive multiagent chemotherapy regimen for brain tumours occurring in very young children. Arch Dis Child (1996) 0.85
Comparative genomic hybridization and histological variation in primitive neuroectodermal tumours. Br J Cancer (1999) 0.85
Treatment developments and the unfolding of the quality of life discussion in childhood medulloblastoma: a review. Childs Nerv Syst (2014) 0.85
Outcome and prognostic factors of desmoplastic medulloblastoma treated within a multidisciplinary treatment concept. BMC Cancer (2010) 0.84
Toward a cure for infants with brain tumours: the challenge for the 1990's. Br J Cancer Suppl (1992) 0.83
p53 protein overexpression identifies a group of central primitive neuroectodermal tumours with poor prognosis. Br J Cancer (1993) 0.83
A review of clinical and histological features of Spanish paediatric medulloblastomas during the last 21 years. Childs Nerv Syst (2005) 0.82
Recent advances in embryonal tumours of the central nervous system. Childs Nerv Syst (2005) 0.82
Antiangiogenic therapy in the treatment of recurrent medulloblastoma in the adult: case report and review of the literature. J Oncol (2009) 0.81
Diagnostic and therapeutic stratification of childhood brain tumors: implications for translational research. J Child Neurol (2008) 0.78
Necrosis after craniospinal irradiation: results from a prospective series of children with central nervous system embryonal tumors. Int J Radiat Oncol Biol Phys (2012) 0.78
Comparison of in vitro activity of epipodophyllotoxins with other chemotherapeutic agents in human medulloblastomas. Br J Cancer (1991) 0.78
Supratentorial tumours in infants. Childs Nerv Syst (1994) 0.78
Medulloblastoma. J Child Neurol (2015) 0.77
Medulloblastoma. Arch Dis Child (1992) 0.75
Clinical Outcomes Among Children With Standard-Risk Medulloblastoma Treated With Proton and Photon Radiation Therapy: A Comparison of Disease Control and Overall Survival. Int J Radiat Oncol Biol Phys (2015) 0.75
Evolution of cerebral microbleeds after cranial irradiation in medulloblastoma patients. Neurology (2017) 0.75
Preradiation Chemotherapy for Adult High-risk Medulloblastoma: A Trial of the ECOG-ACRIN Cancer Research Group (E4397). Am J Clin Oncol (2016) 0.75
Appraisal of the current staging system for residual medulloblastoma by volumetric analysis. Childs Nerv Syst (2011) 0.75
Poor prognosis infantile fibrosarcoma with pathologic features of malignant fibrous histiocytoma after local recurrence. Med Pediatr Oncol (1990) 2.67
P53 germline mutations in childhood cancers and cancer risk for carrier individuals. Br J Cancer (2000) 2.35
Results of the Sixth International Society of Pediatric Oncology Wilms' Tumor Trial and Study: a risk-adapted therapeutic approach in Wilms' tumor. J Clin Oncol (1993) 1.88
The treatment and prognosis of medulloblastoma in children. A study of 82 verified cases. Am J Roentgenol Radium Ther Nucl Med (1969) 1.86
Radiation and genetic factors in the risk of second malignant neoplasms after a first cancer in childhood. Lancet (1997) 1.84
Effect of hypothalamic and pituitary irradiation on pubertal development in children with cranial tumors. J Clin Endocrinol Metab (1982) 1.78
Results of the United Kingdom Children's Cancer Study Group first Wilms' Tumor Study. J Clin Oncol (1995) 1.74
N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study. Neuroblastoma Study Group of the Société Francaise d'Oncologie Pédiatrique. J Clin Oncol (1997) 1.59
Host resistance and survival in carcinoma of breast: a study of 104 cases of medullary carcinoma in a series of 1,411 cases of breast cancer followed for 20 years. Br Med J (1970) 1.59
Some chronic lymphocytic leukemia cells bearing surface immunoglobulins share determinants with T cells. Eur J Immunol (1978) 1.58
An antigen shared by a human T cell subset and B cell chronic lymphocytic leukemic cells. Distribution on normal and malignant lymphoid cells. J Exp Med (1980) 1.50
Pancreatoblastoma: response to chemotherapy. Med Pediatr Oncol (1991) 1.49
High-dose busulfan and thiotepa with autologous bone marrow transplantation in childhood malignant brain tumors: a phase II study. Bone Marrow Transplant (1992) 1.49
Dural sinus thrombosis in children with cancer. Med Pediatr Oncol (1997) 1.45
Effectiveness of preoperative chemotherapy in Wilms' tumor: results of an International Society of Paediatric Oncology (SIOP) clinical trial. J Clin Oncol (1983) 1.39
Wilms' tumor: natural history and prognostic factors: a retrospective study of 248 cases treated at the Institut Gustave-Roussy 1952-1967. Cancer (1976) 1.39
The management of deeply infiltrating (T3) bladder carcinoma: controlled trial of radical radiotherapy versus preoperative radiotherapy and radical cystectomy (first report). Br J Urol (1976) 1.38
Is there a place for radiation therapy in the management of hepatoblastomas and hepatocellular carcinomas in children? Int J Radiat Oncol Biol Phys (1992) 1.34
Treatment of T3 bladder cancer: controlled trial of pre-operative radiotherapy and radical cystectomy versus radical radiotherapy. Br J Urol (1982) 1.33
Osteosarcoma recurrences in pediatric patients previously treated with intensive chemotherapy. J Clin Oncol (1994) 1.32
Radiation dose, chemotherapy and risk of osteosarcoma after solid tumours during childhood. Int J Cancer (1998) 1.32
Pineal and CNS germ cell tumors: Royal Marsden Hospital experience 1962-1987. Int J Radiat Oncol Biol Phys (1990) 1.25
Intracranial tumors: response and resistance to therapeutic endeavors, 1970-1980. Int J Radiat Oncol Biol Phys (1982) 1.22
Proceedings: Hormone-induced and spontaneous regression of metastatic renal cancer. Cancer (1973) 1.18
Glioblastoma multiforme: a controlled trial to assess the value of specific active immunotherapy in patients treated by radical surgery and radiotherapy. Br J Cancer (1973) 1.17
Presence of circulating antibodies against cellular protein p53 in a notable proportion of children with B-cell lymphoma. Int J Cancer (1987) 1.17
Survival among women with cancer of the uterine cervix: influence of marital status and social class. J Epidemiol Community Health (1990) 1.15
Squamous and adenocarcinoma of the uterine cervix: a comparison using routine data. Br J Cancer (1987) 1.15
Two families with the Li-Fraumeni cancer family syndrome. J Med Genet (1982) 1.14
Combined modality therapy for intracranial tumors. Cancer (1975) 1.14
Prognostic significance of cell surface markers in childhood acute lymphoblastic leukaemia. Clin Lab Haematol (1979) 1.14
Thyroid carcinomas after irradiation for a first cancer during childhood. Arch Intern Med (2000) 1.13
Lymph node invasion and prognosis in nephroblastoma. Cancer (1980) 1.13
Localized childhood Hodgkin's disease: response-adapted chemotherapy with etoposide, bleomycin, vinblastine, and prednisone before low-dose radiation therapy-results of the French Society of Pediatric Oncology Study MDH90. J Clin Oncol (2000) 1.11
Primitive neuroectodermal tumours of the cerebrum. Pathology and treatment. J Neurooncol (1985) 1.09
Correlation of MDR1 gene expression with chemotherapy in neuroblastoma. J Natl Cancer Inst (1989) 1.08
Second malignant neoplasms following childhood Hodgkin's disease: treatment and splenectomy as risk factors. Med Pediatr Oncol (1989) 1.08
Malignant mesothelioma of the pleura: a study of 52 treated and 64 untreated patients. Thorax (1984) 1.08
Effects of pulmonary function of whole lung irradiation for Wilm's tumour in children. Thorax (1982) 1.07
Medulloblastoma in children: increasing survival rates and further prospects. Int J Radiat Oncol Biol Phys (1982) 1.07
Human T cell differentiation antigens and correlation of their expression with various markers of T cell maturation. J Immunol (1979) 1.06
Screening for germ line p53 mutations in children with malignant tumors and a family history of cancer. Cancer Res (1993) 1.06
Differentiated thyroid carcinoma in childhood: long term follow-up of 72 patients. J Clin Endocrinol Metab (1987) 1.05
Male gonadal function after chemotherapy for solid tumors in childhood. J Clin Oncol (1989) 1.04
Prognostic significance of peritumoral vascular invasion in breast cancer. Br J Cancer (1984) 1.04
Urinary excretion of 3-methoxy-4-hydroxymandelic acid and 3-methoxy-4-hydroxyphenylacetic acid by 288 patients with neuroblastoma and related neural crest tumors. Cancer Res (1980) 1.04
Second malignant neoplasms after a first cancer in childhood: temporal pattern of risk according to type of treatment. Br J Cancer (1999) 1.04
Subsets of malignant lymphomas in children related to the cell phenotype. Blood (1979) 1.03
Short duration, high dose, alternating chemotherapy in metastatic neuroblastoma. (ENSG 3C induction regimen). The European Neuroblastoma Study Group. Br J Cancer (1990) 1.03
Hemorrhagic cystitis following high-dose chemotherapy and bone marrow transplantation in children with malignancies: incidence, clinical course, and outcome. J Clin Oncol (1989) 1.01
Impact of tumor grade and host resistance on survival of women with breast cancer. Cancer (1971) 1.01
Craniopharyngioma--a long-term results following limited surgery and radiotherapy. Radiother Oncol (1993) 1.00
Decreased risk of radiation-associated second malignant neoplasms in actinomycin-D-treated patients. Cancer (1976) 1.00
Adjuvant chemotherapy in T3 carcinoma of the bladder. A prospective trial: preliminary report. Br J Urol (1988) 0.99
Non-T, non-B lymphomas are rare in childhood and associated with cutaneous tumor. Blood (1982) 0.98
Intracranial ependymoma: long-term results of a policy of surgery and radiotherapy. Int J Radiat Oncol Biol Phys (1992) 0.97
Serum alpha-1 foeto-protein (fetuin) in children with malignant ovarian or testicular teratomas. Preliminary results. Int J Cancer (1969) 0.97
Percutaneous renal surgery and local radiotherapy in the management of renal pelvic transitional cell carcinoma. Br J Urol (1986) 0.97
Bone sarcoma as a second malignant neoplasm in children: influence of radiation and genetic predisposition for the Late Effects Study Group. Cancer (1980) 0.97
Risk factors for hepatic veno-occlusive disease after high-dose busulfan-containing regimens followed by autologous bone marrow transplantation: a study in 136 children. Bone Marrow Transplant (1992) 0.96
Dose-dependent neurotoxicity of high-dose busulfan in children: a clinical and pharmacological study. Cancer Res (1990) 0.96
Rarity of surgical complications after postchemotherapy nephrectomy for nephroblastoma. Experience of the International Society of Paediatric Oncology-Trial and Study "SIOP-9". International Society of Paediatric Oncology Nephroblastoma Trial and Study Committee. Eur J Pediatr Surg (1998) 0.95
Fast neutrons compared with megavoltage x-rays in the treatment of patients with supratentorial glioblastoma: a controlled pilot study. Int J Radiat Oncol Biol Phys (1980) 0.95
Recent concepts in the conservative treatment of intracranial tumours in children. Acta Neurochir (Wien) (1979) 0.94
Hypercalcemia preferentially occurs in unusual forms of childhood non-Hodgkin's lymphoma, rhabdomyosarcoma, and Wilms' tumor. A study of 11 cases. Cancer (1984) 0.94
Wilm's tumor with pulmonary metastases at diagnosis: the significance of primary chemotherapy. International Society of Pediatric Oncology Nephroblastoma Trial and Study Committee. J Clin Oncol (1990) 0.94
Combined analysis of DNA ploidy index and N-myc genomic content in neuroblastoma. Cancer Res (1991) 0.93
Pain in children aged 2-6 years: a new observational rating scale elaborated in a pediatric oncology unit--preliminary report. Pain (1987) 0.93
Pheochromocytoma and paraganglioma in children: a report of 24 cases of the French Society of Pediatric Oncology. Pediatr Hematol Oncol (1997) 0.93
Surface antigens on malignant Sézary and T-CLL cells correspond to those of mature T cells. Blood (1981) 0.93
Bilateral Wilms' tumor: long-term survival and some epidemiological features. J Clin Oncol (1989) 0.93
Cell-mediated immunity and blocking factors in patients with tumours of the central nervous system. Int J Cancer (1973) 0.92
Pharmacokinetics of high-dose busulfan in children. Cancer Chemother Pharmacol (1989) 0.92
Results of the LMT81 protocol, a modified LSA2L2 protocol with high dose methotrexate, on 84 children with non-B-cell (lymphoblastic) lymphoma. Med Pediatr Oncol (1992) 0.91
Growth hormone deficiency in children with brain tumors. Cancer (1976) 0.91
High dose BCNU chemotherapy with autologous bone marrow transplantation and full dose radiotherapy for grade IV astrocytoma. Br J Cancer (1988) 0.91
Long-term psychological effects in children treated for intracranial tumors. Int J Radiat Oncol Biol Phys (1990) 0.90
[The role of intubation and artificial ventilation in the treatment of severe bronchoalveolitis in infants. (Apropos of 7 cases)]. Arch Fr Pediatr (1967) 0.90
Rhabdomyosarcoma in infants under one year of age: experience of the Institut Gustave-Roussy. Med Pediatr Oncol (1989) 0.90
Genome-wide loss of maternal alleles in a nephrogenic rest and Wilms' tumour from a BWS patient. Hum Genet (1995) 0.89
Germ-line exclusion of a single p53 allele by premature termination of translation in a Li-Fraumeni syndrome family. Oncogene (1994) 0.89
Treatment of stage IV-S neuroblastoma: a study of 34 cases treated between 1982 and 1987. Med Pediatr Oncol (1991) 0.89
Increased brown adipose tissue activity in children with malignant disease. Horm Metab Res (1989) 0.89
The role of radiotherapy in the management of intracranial meningiomas: the Royal Marsden Hospital experience with 186 patients. Int J Radiat Oncol Biol Phys (1990) 0.89
Radiation enteritis in children. A retrospective review, clinicopathologic correlation, and dietary management. Cancer (1975) 0.89
Rhabdomyosarcoma of the larynx in children: a series of five patients treated in the Institut Gustave Roussy (Villejuif, France). Med Pediatr Oncol (1991) 0.89
[Neuroblastomas treated at the Gustave-Roussy Institute from 1975 to 1979. 173 cases]. Arch Fr Pediatr (1983) 0.88
[Treatment of childhood cancer in Africa. Preliminary results of the French-African paediatric oncology group]. Arch Pediatr (2005) 0.88
The natural history of untreated breast cancer. Ann N Y Acad Sci (1964) 0.88
Busulfan disposition and hepatic veno-occlusive disease in children undergoing bone marrow transplantation. Cancer Chemother Pharmacol (1996) 0.88
[Presence of a ferroprotein of tissue origin, the alpha-2H globulin, in sera of children with tumors]. Int J Cancer (1970) 0.88
Is 600 mg/m2 the appropriate dosage of busulfan in children undergoing bone marrow transplantation? Blood (1992) 0.88
Methotrexate treatment for advanced bladder cancer. Br J Urol (1974) 0.87
Postoperative radiotherapy in the management of spinal cord ependymoma. J Neurosurg (1991) 0.87
Treatment of advanced neuroblastoma with high-dose melphalan and autologous bone marrow transplantation. Cancer Chemother Pharmacol (1986) 0.87
Optimal treatment of clinical stage I yolk sac tumor of the testis in children. J Pediatr Surg (1986) 0.87
Genetic transmission of susceptibility to cancer in families of children with soft tissue sarcomas. Cancer (1996) 0.87
Streptococcal septicaemia following autologous bone marrow transplantation in children treated with high-dose chemotherapy. Bone Marrow Transplant (1991) 0.87